Clean Yield Group reduced its stake in Colgate-Palmolive (NYSE:CL – Free Report) by 0.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 20,725 shares of the company’s stock after selling 155 shares during the quarter. Clean Yield Group’s holdings in Colgate-Palmolive were worth $1,884,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of CL. State Street Corp lifted its holdings in shares of Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock valued at $5,028,170,000 after buying an additional 1,784,411 shares during the period. Geode Capital Management LLC raised its position in Colgate-Palmolive by 2.8% in the third quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company’s stock worth $2,095,325,000 after acquiring an additional 552,949 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in Colgate-Palmolive by 6.2% in the third quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company’s stock valued at $988,997,000 after acquiring an additional 557,492 shares during the period. Legal & General Group Plc boosted its position in shares of Colgate-Palmolive by 0.8% during the 2nd quarter. Legal & General Group Plc now owns 7,785,101 shares of the company’s stock worth $755,465,000 after purchasing an additional 61,413 shares in the last quarter. Finally, Barclays PLC increased its holdings in shares of Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after purchasing an additional 2,132,747 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Stock Up 1.0 %
CL traded up $0.85 on Monday, reaching $87.21. The company’s stock had a trading volume of 4,950,406 shares, compared to its average volume of 4,821,303. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a 1 year low of $79.69 and a 1 year high of $109.30. The business’s 50 day moving average is $92.62 and its 200 day moving average is $98.06. The stock has a market cap of $71.25 billion, a price-to-earnings ratio of 24.99, a price-to-earnings-growth ratio of 3.31 and a beta of 0.44.
Colgate-Palmolive Announces Dividend
Wall Street Analysts Forecast Growth
A number of analysts have commented on the company. Stifel Nicolaus downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their target price for the stock from $105.00 to $101.00 in a research report on Monday, October 28th. TD Cowen decreased their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. JPMorgan Chase & Co. boosted their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Piper Sandler reduced their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. Finally, StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $103.63.
Get Our Latest Report on Colgate-Palmolive
Insider Activity at Colgate-Palmolive
In related news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.34% of the stock is owned by corporate insiders.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
- Five stocks we like better than Colgate-Palmolive
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- What Are the U.K. Market Holidays? How to Invest and Trade
- Delta Can Fly to New Highs in 2025; Here’s Why
- How to trade using analyst ratings
- Snowflake Stock: Bullish Upgrades Demand Investors’ Attention
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.